• You are invited to learn more about the newest area of Innovation Laboratories, Inc’s research on PureWay-CŪ
• Human clinical study completed shows PureWay-CŪ is a superior form of vitamin C • Positive effects of PureWay-CŪ on marker of oxidative stress and biomarkers of inflammation • PureWay-CŪ is a unique patent-pending form of vitamin C directly associated with greater reduction of plasma levels of C-reactive protein and oxidized LDL, beneficially impacting on the cardiovascular and immunological systems.
• PureWay-CŪ is more rapidly absorbed and more highly retained by the human body than other vitamin C preparations. • PureWay-CŪ has more rapid and greater benefits on cells of: • The Nervous system • Wound healing activities • The Immune system • PureWay-CŪ Is One of The Most Advanced form of Vitamin C Available! • Investigators publish new data in the report 'Absorption rates and free radical scavenging values of vitamin C-lipid metabolites in human lymphoblastic cells.' According to a study from the United States, "In this study we investigated the cellular absorption rates, antioxidant and free radical scavenging activity of vitamin C-lipid metabolites (see also Cell Biology) (http://www.newsrx.com/library/topics/Cell-Biology.html). • PureWay-CŪ is more rapidly absorbed to higher levels by human cells • The Discovery and Uses of a Novel Vitamin C Preparation: PureWay-CŪ • PureWays-CŪ is better absorbed and retained to higher serum levels by humans in clinical studies • A novel vitamin C preparation enhances neurite formation and fibroblast adhesion and reduces xenobiotic-induced T-cell hyperactivation. Med Sci Monit. 2007 Mar;13(3):BR51-8. PMID: 17325628 • Absorption rates and free radical scavenging values of vitamin C-lipid metabolites in human lymphoblastic cells. Med Sci Monit. 2007 Oct;13(10):BR205-210. PMID: 17901843 [PubMed] • ORAC and DPPH values of PureWay-C and other form of vitamin C. PubMed - in process] • Vitamin C-lipid metabolites: Uptake and Retention and Effect on Plasma C-Reactive Protein and Oxidized LDL levels in Healthy Volunteers [PubMed - in process] • Conducted clinical study on comparative effects of PureWay-C versus other vitamin C formulations at the University of Miami; 2007 [PubMed - in process] • PureWay-CŪ delivers effective antioxidant and free radical scavenging activity using the (ORAC) and (DPPH) methods. • See Clinical Study on PolicosanolPlusŪ at the University of Miami (2001 – 2002) • See Open Label, Single Center Study. PolicosanolPlusŪ and lipid Lowering agents, results, recommendations and future directions at The University of Miami (2004) • See publication on JANA (The Journal of the American Nutraceutical Association) (PolicosanolPlusŪ and Neuroprevin™ Enhance Neurite Regeneration and Prevent Neurite Degeneration: Dietary Supplements for Nerve Repair and Prevention, and Reduction of Neurodegenerative Disorders). The article is available from the Vol.9, No.2 2006 edition of JANA. • See publication on MedSciMonit (Medical Science Monitor) (PolicosanolPlusŪ and Neuroprevin™ ameliorate pesticide-mediated inhibition of neurite outgrowth and neurite degeneration). The article is available from the Vol.12, No.12 2006 edition of MedSciMonit. • See publication on J Pharmacol Exp Ther. 2006 Sep;318(3):1020-1026. (Policosanol inhibits cholesterol synthesis in hepatoma cells by activation of AMP-kinase). Several of the participants were immunosuppressed either with Cancer, HIV or Hepatitis C. These patients reported improvements in areas such as general well-being, sleep, mental, physical condition and had no viral syndrome or illnesses during their supplement phase. This may be related to overall Natural Killer cell activity. Natural Killer cell activity may be a more sensitive marker than overall quantitative measurement. • See publication on JANA (The Journal of the American Nutraceutical Association) (Pilot Study: Effect of PDS-2865 on Natural Killer Cell on Citotoxicity). The article is available from the Vol.6, No.2 Spring 2003 edition of JANA. • See conducted research study on Natramune™ (PDS-2865Ū) at the Biological Sciences, Adelphi University; 2006-2007. • See conducted clinical study on Natramune™ (PDS-2865Ū) at the Miami Seaquarium and University of California Veterinary Medicine Immunology Laboratory; 2006 to 2007. Oral administration of Natramune™ (PDS-2865Ū) to animals of the Cetacean Species: Effects on the Immune System. • Innovation Laboratories, Inc announces trademark approval PureWay-CŪ and related logos are registered trademark of Innovation Laboratories, Inc PureWay-CŪ is manufactured exclusively by Innovation Laboratories, Inc | |   One of The Most Advanced Form of Vitamin C Available! A Superior Form of Vitamin C! The Proof Is In The Research!
| |
PureWay-CŪ Market Status: Data and Competitive Advantages Why PureWay-CŪ is superior to other vitamin C preparations Top reasons why PureWay-CŪ makes a difference: Unique Product • No competition from others with the same composition • Composition, manufacturing process and its method of use are patent-pending • PureWay-CŪ is trademark protected in several international class covered varieties of goods and services. Efficacy • Documented efficacy in research studies (published, unpublished but already submitted to peer review magazine, and in progress with promising and positive superior results in humans) even when compared to other vitamin C preparations • The Proof is in the Research! Peripheral Benefits • More rapidly taken-up and absorbed by cells than other forms of vitamin C • PureWay-CŪ demonstrated the best absorption rates of all forms of vitamin C tested for all time points • More rapidly adsorbed and more highly retained by the human body than other traditional forms of vitamin C • PureWay-CŪ is directly associated with greater reduction of plasma levels of C-reactive protein and Oxidized LDL in human clinical study • Potent antioxidant and significant free radical scavenging capabilities • Antioxidant Protection • PureWay-CŪ delivers effective antioxidant and free radical scavenging activity • Antioxidants fight free radicals •PureWay-CŪ showed a 93% scavenging of DPPH free radicals • Faster and greater beneficial effects than other forms of vitamin C • More rapidly stimulated healthy neurons • More rapidly promoted wound healing • More rapidly protected immune system To date, the research confirms that: • The Proof is in the Research! • Taken together for each of the above researched beneficial activities, PureWay-CŪ has been shown to act more quickly than any other tested vitamin C • The more rapid cellular localization of PureWay-CŪ compared to other forms of vitamin C explains the ability of this formulation to better enhance benefits and correlate to an improved protection • The increase rate of absorption of PureWay-CŪ correlated with a greater protective effects • The rapid uptake explains the ability of the PureWay-CŪ to better exert these benefits • The research studies showed that PureWay-CŪ has better absorption kinetics and becomes more available with better protective benefits than other tested forms of vitamin C PureWay-CŪ: It works. It’s natural. It’s proven. PureWay-CŪ offers an innovative, value-adding solution for companies focused on product improvements or exploring new opportunities to differentiate their brand. The Discovery and Uses of a Novel Vitamin C Preparation: PureWay-CŪ PureWay-CŪ is a newly patent-pending form of vitamin C that contains Vitamin C-lipid metabolites. It is prepared through a proprietary process. The better stimulation of neurite outgrowth, increased fibroblast wound healing activities, and protection of the immune system from xenobiotic induced inflammatory mechanism as well as uptake, concentration, and utilization efficacy of PureWay-CŪ will be discussed during this presentation based on the results from multiples research studies, including a human clinical trial. PureWay-CŪ can be used in dietary and nutritional supplements, functional foods, dairy products, healthy beverages, cosmetics and personal care products, human and animal food, and pharmaceutical preparations. |